
Contributions
Abstract: EP1385
Type: Poster Sessions
Abstract Category: Clinical aspects of MS - MS symptoms
Fatigue is the most commonly reported symptom in multiple sclerosis (MS) and is observed in 53-97% of people with MS (pwMS). The presence of fatigue lowers the quality of life and pwMS generally regard fatigue as the most disturbing symptom. Disease duration, disability level, number of attacks, sleep quality and depression levels may be associated with fatigue in pwMS.
The aim was to compare the duration of disease, level of disability, number of attacks, sleep quality and depression levels in pwMS with or without fatigue.
In total, 373 pwMS enrolled in this study. The levels of disability, sleepiness and depression were assessed with the Extended Disability Status Scale (EDSS), the Epworth Sleepiness Scale, and the Beck Depression Scale, respectively. The level of fatigue was assessed with the Modified Fatigue Impact Scale (MFIS) and 38 points for fatigue were considered cut-off values.
The fatigue was detected in 242 participants (64.88%).Duration of disease, disability level, number of attacks, daytime somnolence and depression levels were significantly higher in participants with fatigue than participants without fatigue (p < 0.05).
This study has suggested that pwMS with fatigue have more disease duration, disability level, number of attacks, daytime sleepiness and depression levels than without fatigue. While the evaluation and rehabilitation programs for fatigue are being organized, the duration of illness, disability level, number of attacks, sleep quality and depression levels should also be considered.
Disclosure: Yuksel Yorgun: nothing to disclose
Asiye Tuba Ozdogar: nothing to disclose
Taha Aslan: nothing to disclose
Cavid Babayev: nothing to disclose
Ozge Sagici: nothing to disclose
Turhan Kahraman: nothing to disclose
Serkan Ozakbas: nothing to disclose
Abstract: EP1385
Type: Poster Sessions
Abstract Category: Clinical aspects of MS - MS symptoms
Fatigue is the most commonly reported symptom in multiple sclerosis (MS) and is observed in 53-97% of people with MS (pwMS). The presence of fatigue lowers the quality of life and pwMS generally regard fatigue as the most disturbing symptom. Disease duration, disability level, number of attacks, sleep quality and depression levels may be associated with fatigue in pwMS.
The aim was to compare the duration of disease, level of disability, number of attacks, sleep quality and depression levels in pwMS with or without fatigue.
In total, 373 pwMS enrolled in this study. The levels of disability, sleepiness and depression were assessed with the Extended Disability Status Scale (EDSS), the Epworth Sleepiness Scale, and the Beck Depression Scale, respectively. The level of fatigue was assessed with the Modified Fatigue Impact Scale (MFIS) and 38 points for fatigue were considered cut-off values.
The fatigue was detected in 242 participants (64.88%).Duration of disease, disability level, number of attacks, daytime somnolence and depression levels were significantly higher in participants with fatigue than participants without fatigue (p < 0.05).
This study has suggested that pwMS with fatigue have more disease duration, disability level, number of attacks, daytime sleepiness and depression levels than without fatigue. While the evaluation and rehabilitation programs for fatigue are being organized, the duration of illness, disability level, number of attacks, sleep quality and depression levels should also be considered.
Disclosure: Yuksel Yorgun: nothing to disclose
Asiye Tuba Ozdogar: nothing to disclose
Taha Aslan: nothing to disclose
Cavid Babayev: nothing to disclose
Ozge Sagici: nothing to disclose
Turhan Kahraman: nothing to disclose
Serkan Ozakbas: nothing to disclose